Completed PHASE1 INTERVENTIONAL NCT00073632

Acceptance-Based Treatment for Generalized Anxiety Disorder

Developing a New Therapy for GAD: Acceptance-Based CBT

Sponsor: National Institute of Mental Health (NIMH)

Conditions Anxiety Disorders Generalized Anxiety Disorder

Interventions Acceptance Based Behavioral Therapy

Updated 5 times since 2017 Last updated: Nov 5, 2013 Started: May 31, 2002 Primary completion: Jul 31, 2006 Completion: Aug 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Anxiety Disorders and Generalized Anxiety Disorder and is currently completed. National Institute of Mental Health (NIMH) leads this study, which shows 5 recorded versions since 2002 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

May 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)
University of Massachusetts, Boston

Data source: University of Massachusetts, Boston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States